SBIR/STTR Research Award
Nanowire Sensor Array-based Assay for Early Diagnosis of Alzheimer's Disease
Award amount
$224,999Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- INNOSENSE CORPORATION
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Y45MWN6YRAB1
- Solicitation number
- PA13-234
- Topic code
- NIA
Research abstract
DESCRIPTION (provided by applicant): Over 5 million Americans are currently believed to have Alzheimer's disease (AD), the most common form of dementia. This number could reach 16 million by 2050. AD is a terminal, progressive brain disorder with no knowncause or cure. AD leads to memory loss, confusion, impaired judgment, personality changes, disorientation, and the inability to communicate. The Alzheimer's Association estimates that 450,000 people will die with Alzheimer's, meaning they will die after developing the disease. The cost of care is estimated to be 203 billion in the United States in 2013. In addition, 15.4 million Americans provide unpaid care valued at 216 billion for persons with Alzheimer's and other forms of dementia. Currently, there is no definitive clinical diagnosis for AD other than a postmortem autopsy. Because early diagnosis could enable better planned and coordinated care, there is an urgent need to develop a cost-effective, highly sensitive and selective early stage diagnostic
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Electrochemical Detection of Salts Using MOF-Composite Electrodes for Space Applications
- Wrap-able, Radiation-Resistant Electrical Insulators for Superconducting Magnet Applications
- Nanomaterials-Enabled Biodiesel Composition Detector
- Nanomaterials Based Gas Sensor for ISRU Process Contaminants
- Manipulation of Enabling Microbial Systems for Improved Bioenergy Crops
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease
Research funding history
141 SBIR/STTR records share this UEI (2004–2024). Reported award amounts total $58,902,557. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Energy, National Aeronautics and Space Administration, Department of Defense, Department of Health and Human Services, National Science Foundation, Environmental Protection Agency